Special Issue "Pharmacogenetics of Treating Anxiety & Depression"
Deadline for manuscript submissions: closed (31 March 2022) | Viewed by 11115
2. Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA
3. College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA
Interests: pharmacogenetics of antidepressants; methotrexate pharmacogenetics & pharmacokinetics; pediatric pharmacogenetic implementation; model-informed precision dosing
Pharmacogenetics has the potential to improve the treatment of anxiety and depression. Though some institutions have been implementing pharmacogenetics in the clinical care of patients with anxiety and depression for many years, there is still much more research to be done. The aim of this Special Issue is to provide a comprehensive overview of how pharmacogenetics can influence the efficacy and tolerability of medications used to treat anxiety and depression, the current state of research in this area, and the challenges and opportunities for implementation in clinical care.
Articles may be in the areas of discovery, replication, trial design, position papers, meta-analyses, or a description of your implementation. Articles may be in the form of research article, review paper, or communication.Dr. Laura B. Ramsey
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Anxiety disorders
- Depressive disorders
- Clinical trials